目的 总结羊水栓塞患者的临床资料,探讨羊水栓塞的发生机制,分享羊水栓塞救治经验。方法 回顾性分析2011-03至2018-11在北京妇产医院孕晚期分娩并发羊水栓塞患者的症状、体征、实验室等辅助检查、用药救治过程,以及母儿妊娠结局与预后。结果 在109 401次孕晚期分娩记录中,共发生13例羊水栓塞,发病率11.88/10万。高龄(超过35岁)产妇占比53.8%(7/13),经产妇占比53.8%(7/13),存在过敏性体质患者4例,胎盘高危因素4例,妊娠期高血压疾病患者3例。84.6%(11/13)的患者出现了危及生命体征的临床表现(至少低血压、低血氧、DIC之一),3例出现心脏呼吸骤停,5例并发DIC,产后出血(>1000 ml以上)者9例[1100~6000 ml,(2963±406)ml]。4例血液中查找羊水成分,其中3例阳性,9例使用大量血管活性药物时间超过3 h,5例行子宫切除术,无患者死亡。结论 羊水栓塞主要依靠临床表现进行诊断;典型的羊水栓塞是产科罕见而凶险的并发症;及时准确的诊断以及训练有素的多学科快速反应团队,及时足量的抗过敏和血管活性药物以及后续充分的生命支持治疗是挽救羊水栓塞患者生命的关键措施。
Abstract
Objective To summarize the clinical data of amniotic fluid embolism and to explore the mechanism of amniotic fluid embolism.Methods From March 2011 to November 2018, the symptoms, signs, laboratory examinations, medication treatment, maternal and fetal pregnancy outcomes and prognosis of patients with amniotic fluid embolism during late pregnancy in Beijing Obstetrics and Gynecology Hospital were retrospectively recorded.Results Among the 109401 late pregnancy delivery records in our hospital, there were 13 cases of amniotic fluid embolism, with an incidence of 11.88/100 000, 53.8% (7/13) of pregnant women over 35 years old, 53.8% (7/13) of multipartum, 4 cases of allergic history, 4 cases of high placental risk factors, and 3 cases of pregnancy-induced hypertension. 84.6% (11/13) of the patients had at least one of clinical life-threatening signs (and/or hypotension, hypoxia, DIC), 3 patients had cardiac arrest, 5 patients had DIC, and 9 patients had postpartum hemorrhage (more than 1000 ml) [1100-6000 ml, (2963±406) ml]. Among the 4 patients, 3 were positive for amniotic fluid components from blood samples, 9 were treated with large amounts of vasoactive mediaters for more than 3 hours, and 5 underwent hysterectomy without death.Conclusions Amniotic fluid embolism mainly depends on clinical manifestations for diagnosis. Typical amniotic fluid embolism is a rare and extremely dangerous delivery complication. Timely and accurate diagnosis and well-trained multidisciplinary rapid response team, instant and adequate antiallergic and vasoactive drugs and accurate life support therapy are the key measures to save the lives of patients with amniotic fluid embolism.
关键词
羊水栓塞 /
高危因素 /
临床表现 /
诊断与治疗
Key words
amniotic fluid embolism /
high risk factors /
clinical manifestations /
diagnosis and treatment
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 谢 幸,苟文丽.羊水栓塞妇产科学[M].8版. 北京:人民卫生出版社, 2013: 215-218.
[2] 林乐毅,冯 烨, 陆 芸, 等. 羊水栓塞的发病机制与临床诊治特点[J]. 中华围产医学杂志(电子), 2019,22(4):220-222.
[3] Society for Maternal-Fetal Medicine (SMFM). Amniotic fluid embolism: diagnosis and management[J]. Am J Obstet Gynecol, 2016, 215(2): B16-B24.
[4] 中华医学会妇产科学分会产科学组. 羊水栓塞临床诊断与处理专家共识(2018)[J].中华妇产科杂志,2018,56(12):831-835.
[5] Fitzpatrick K E, Tuffnell D, Kurinczuk J, et al. Incidence, risk factors, management and outcomes of amniotic fluid embolism: a population-based cohort and nested case-control study [J]. BJOG, 2016, 123(1): 100-109.
[6] 徐春芳, 王谢桐, 陈延琴. 两次剖宫产术中均发生羊水栓塞1 例[J]. 中国实用妇科与产科杂志,2003,19(5): 318.
[7] Fineschi V. Editorial: “amniotic fluid embolism: novel biomarkers for future diagnostic investigation and therapy” [J]. Curr Pharm Biotechnol,2014,14(14):1155-1156.
[8] Kobayashi H. Amniotic fluid embolism: anaphylactic reactions with idiosyncratic adverse response[J]. Obstet Gynecol Surv, 2015, 70(8):511-517.
[9] Rafael A, Benson M D. Amniotic fluid embolism: then and now[J]. Obstet Med, 2014, 7(1):34-36.
[10] Fineschi V, Gambassi R, Gherardi M, et al. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase[J]. Int J Legal Med, 1998, 111:238-243.
[11] Indraccolo U, Battistoni C, Mastrantonio I, et al. Risk factors for fatality in amniotic fluid embolism:a systematic review and analysis of a data pool[J]. J Matern Fetal Neonatal Med, 2018, 31(5): 661-665.
[12] Tamura N, Farhana M, Oda T, et al. Amniotic fluid embolism: pathophysiology from the perspective of pathology[J]. J Obstet Gynaecol Res,2017,43(4):627-632.
[13] Pacheco L D, Saade G, Hankins G D, et al. Amniotic fluid embolism: diagnosis and management[J]. Society for Maternal-Fetal Medicine (SMFM).Am J Obstet Gynecol,2016, 215(2): B16-24.
[14] 李连鹏, 戴 伟,李 桢. 大鼠羊水栓塞模型的法医病理学检验分析[J]. 中国现代医药杂志, 2018, 20(7): 228-230.
[15] Hession P M, Millward C J, Gottesfeld J E, et al. Amniotic fluid embolism: using the medical staff process to facilitate stream lined care [J]. Perm J,2016,20(4):97-101.
[16] Balinger K J, Chu Lam M T, Hon H H, et al. Amniotic fluid embolism: despite progress, challenges remain[J]. Curr Opin Obstet Gynecol, 2015,20(8):458-463.
[17] Sultan P, Seligman K, Carvalho B. Amniotic fluid embolism: update and review[J]. Curr Opin Anaesthesiol, 2016, 29(3): 288-296.
[18] Fong A, Chau C T, Pan D, et al. Amniotic fluid embolism: antepartum, intrapartum, and demographic factors[J]. J Matern Fetal Neonatal Med,2015,28(7):793-798.
PDF(1036 KB)
